These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34217849)

  • 1. Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation.
    Millán O; Rovira J; Guirado L; Espinosa C; Budde K; Sommerer C; Piñeiro GJ; Diekmann F; Brunet M
    Clin Immunol; 2021 Aug; 229():108792. PubMed ID: 34217849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
    Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
    J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.
    Mayer KA; Omic H; Weseslindtner L; Doberer K; Reindl-Schwaighofer R; Viard T; Tillgren A; Haindl S; Casas S; Eskandary F; Heinzel A; Kozakowski N; Kikić Ž; Böhmig GA; Eder M
    Clin Transplant; 2022 Nov; 36(11):e14785. PubMed ID: 35894263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
    Blydt-Hansen TD; Gibson IW; Gao A; Dufault B; Ho J
    Transplantation; 2015 Apr; 99(4):797-804. PubMed ID: 25222013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
    Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
    Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy.
    Salinas T; Li C; Snopkowski C; Stryjniak G; Shankaranarayanan D; Albakry S; Ding R; Sharma VK; Salvatore SP; Seshan SV; Dadhania DM; Muthukumar T; Suthanthiran M
    J Immunol Methods; 2023 Jan; 512():113402. PubMed ID: 36493873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
    Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
    J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation.
    Matz M; Heinrich F; Zhang Q; Lorkowski C; Seelow E; Wu K; Lachmann N; Addo RK; Durek P; Mashreghi MF; Budde K
    Clin Transplant; 2018 Dec; 32(12):e13429. PubMed ID: 30341925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection.
    Cheungpasitporn W; Kremers WK; Lorenz E; Amer H; Cosio FG; Stegall MD; Gandhi MJ; Schinstock CA
    Clin Transplant; 2018 Mar; 32(3):e13194. PubMed ID: 29315820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in
    Millán O; Ruiz P; Orts L; Ferré P; Crespo G; Santana M; Fortuna V; Quintairos L; Navasa M; Brunet M
    Front Immunol; 2019; 10():873. PubMed ID: 31068943
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy.
    Naef B; Nilsson J; Wuethrich RP; Mueller TF; Schachtner T
    Transpl Int; 2021 Aug; 34(8):1481-1493. PubMed ID: 33872427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection.
    Schiffer L; Wiehler F; Bräsen JH; Gwinner W; Greite R; Kreimann K; Thorenz A; Derlin K; Teng B; Rong S; von Vietinghoff S; Haller H; Mengel M; Pape L; Lerch C; Schiffer M; Gueler F
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
    Aziz F; Jorgenson MR; Parajuli S; Zhong W; Hidalgo LG; Djamali A; Mandelbrot D; Odorico J; Sollinger H; Astor BC; Mohamed MA
    Transpl Infect Dis; 2020 Jun; 22(3):e13272. PubMed ID: 32112710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation.
    Tinel C; Vermorel A; Picciotto D; Morin L; Devresse A; Sauvaget V; Lebreton X; Aouni L; Prié D; Brabant S; Avettand-Fenoel V; Scemla A; Timsit MO; Snanoudj R; Legendre C; Terzi F; Rabant M; Anglicheau D
    Front Immunol; 2020; 11():604353. PubMed ID: 33362789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus-associated nephropathy.
    Shen J; Guo L; Lei W; Liu S; Yan P; Liu H; Zhou J; Zhou Q; Liu F; Jiang T; Wang H; Wu J; Chen J; Wang R
    J Zhejiang Univ Sci B; 2021 Nov; 22(11):917-928. PubMed ID: 34783222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
    Matz M; Lorkowski C; Fabritius K; Wu K; Rudolph B; Frischbutter S; Brakemeier S; Gaedeke J; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():18-24. PubMed ID: 27693310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
    Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.